Journal Article

Expression of the p53 homologue p63α and ΔNp63α in normal and neoplasticcells

Peter A. Hall, Sandra J. Campbell, Mary O'neill, Daniel J. Royston, Karin Nylander, Frank A. Carey and Neil M. Kernohan

in Carcinogenesis

Volume 21, issue 2, pages 153-160
Published in print February 2000 | ISSN: 0143-3334
Published online February 2000 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/21.2.153
Expression of the p53 homologue p63α and ΔNp63α in normal and neoplasticcells

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

A burgeoning family of p53-related genes have been described recently, including p73 and p63. Both these genes encode proteins with many similarities to p53 but also with the potential for forming a range of related species by alternative promoter usage and alternative splicing. In order to begin the characterization of p63, we generated a polyclonal serum (designated SC1) that recognizes the C-terminus of p63α. We have shown that this reagent recognizes p63α but not p53 nor p73. By western blot analysis both p63α and the N-terminal truncated form of p63α (ΔNp63α) were found in a range of cell lines. Similar immunoblot analysis of tissues reveals considerable complexity with at least four SC1-immunoreactive isoforms being identified. In immunohistological studies SC1 immunoreactivity is widely detectable, being predominantly associated with proliferative compartments in epithelia. However, non-proliferative populations can also show SC1 immunostaining. No simple relationship between the isoforms identified by immunoblotting of tissue lysates and the tissue immunostaining characteristics was identified. A previously unrecognized species intermediate in mobility between p63α and ΔNp63α was found in several tissues, including nerve and peripheral blood lymphocytes. Interestingly, there is suppression of p63α expression in HaCat cells in a time- and concentration-dependent manner after UV and MMS treatment. Our data provide further information about the complexity of p63 and the SC1 serum will prove to be a useful tool in further studies of this p53 homologue.

Keywords: LMS, limb mammary syndrome; PBST, phosphate-buffered saline and 0.1% Tween 20.

Journal Article.  6836 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.